Tenable Holdings Inc <TENB.O>: TD Cowen raises target price to $44 from $38
TENB•Related News
Aligos completes enrollment in Phase 2 B-SUPREME trial for chronic hepatitis B drug pevifoscorvir sodium
ALGS•
Nasdaq trade halt continues UCFIW.O reason not available at 09:00 AM
UCFIW•
Intel to upgrade, expand Irish manufacturing hub with $5.7 bln investment
INTC•
California Resources Corp <CRC.N>: JP Morgan Cuts Target Price to $77 From $83
CRC•
Resideo Technologies Inc <REZI.N>: Morgan Stanley cuts target price to $45 from $50
REZI•